We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1,360.00 | 1,359.50 | 1,360.00 | 1,361.00 | 1,354.50 | 1,355.00 | 590,401 | 10:50:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1889 | 11.41 | 56.37B |
Date | Subject | Author | Discuss |
---|---|---|---|
11/6/2009 13:44 | Look at the buyer v seller, really building upon the buying side. Awaiting Level 6 upgrade from WHO, anytime this afternoon. | montyhedge | |
11/6/2009 13:39 | GSK Adrs in US looking very good trading at 1061p. | montyhedge | |
11/6/2009 11:21 | For once I agree with you Monty. | sat69 | |
11/6/2009 11:16 | All looking good, underpriced, but about to change. | montyhedge | |
11/6/2009 11:15 | LONDON (SHARECAST) - The share price of drugs giant GlaxoSmithKline has moved sideways since the start of March and has some catching up to do in relation to the share price performance of its European peers, reckons Morgan Stanley. The US bank has upgraded its rating on the stock from 'underweight' to 'equal weight' and set a price target of 1320p as part of a review of the European pharmaceutical sector. GSK's shares have underperformed the European pharmaceuticals sector by 12% in the year to date. 'Longer-term, we continue to strongly endorse the chief executive's dynamic strategy in moving towards a diversified healthcare model, which we believe will create significant shareholder value long-term,' said Morgan Stanley analyst Andrew Baum. | spondon2 | |
11/6/2009 11:12 | Once announced countries have to stock more drugs. | montyhedge | |
11/6/2009 11:09 | Level 6 will be announced later this afternoon. First time in 40 years, 1155p GSK. | montyhedge | |
11/6/2009 10:56 | Sat Why miss GSK for a sake of a few pence still a long way to go. 1155p here we come. | montyhedge | |
11/6/2009 10:53 | Good call this time Monty. I guess when you're long one day and short the next, the law of averages says you will be right 50% of the time! :-) | sat69 | |
11/6/2009 10:46 | First level 6 for 40 years. | montyhedge | |
11/6/2009 10:45 | ANNOUNCEMENT FROM WHO THIS AFTERNOON UPGRADE SWINE FLU TO LEVEL 6, WATCH US FLY TOMORROW. | montyhedge | |
11/6/2009 10:41 | £12 Target upgrade. Still time to get long | onehanded | |
11/6/2009 10:31 | For traders quick 100p to be in a couple of days, for investors dividend every 12 weeks plus capital growth, we all win except bears in the stock. | montyhedge | |
11/6/2009 09:46 | GSK its a no brainer, Goldman Sach upgrade today, 3pm WHO announce Level 6, first time in 40 years. Tomorrow is real take off for us. 1155p easily. | montyhedge | |
11/6/2009 09:30 | Goldman Sach upgrades GSK this morning, ah all looking good. | montyhedge | |
11/6/2009 09:29 | I have no posi Monty. Wanted to buy at 1024p but didn't get there. I don't short individual stocks. | sat69 | |
11/6/2009 09:27 | grah Short at 1057p you will regret that later today, when WHO announced level 6. That means countries have to have more stocks of drugs. | montyhedge | |
11/6/2009 09:26 | Every quarter, next ex 29th July. sat69 hope you are not short. | montyhedge | |
11/6/2009 09:24 | Monty - Can you remind me how often the divi is paid? | sat69 | |
11/6/2009 09:23 | Chartists saying 1275p, but must admit never heard of or met a rich chartist. | montyhedge | |
11/6/2009 09:18 | Also Goldman Sach upgrade GSK, its all looking good, 1155p here we come. | montyhedge | |
11/6/2009 09:14 | IT WILL ANNOUNCED AROUND 3PM LEVEL 6. GSK WILL GO TO 1150P EASILY. | montyhedge | |
11/6/2009 09:11 | WHO TO ANNOUNCED LATER TODAY LEVEL 6 FOR SWINE FLU FIRST TIME IN 40 YEARS. ORDERS POURING IN FOR GSK DRUG. | montyhedge |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions